Eicosapentaenoic acid and docosahexaenoic acid in fish oil capsule supplementation in obese children decreases serum interleukin-6 and hepcidin and improves iron status
- PDF |
- DOI: https://doi.org/10.15562/bmj.v6i1.410 |
- Published: 2017-02-18
Open Access & Peer Reviewed Multidisciplinary
Journal of Medical Sciences
Journal of Medical Sciences
Abstract
Background: Chronic low-grade inflammation in obese children causes iron restriction, resulting in hypoferremia. Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA), active metabolites of long chain n-3 polyunsaturated fatty acid have an anti-inflammatory effect. Objective: We investigated the effect EPA and DHA in fish oil capsule supplementation on inflammation and iron status in obese children. Methods: A double-blind randomized controlled trial was conducted among 70 obese children aged six to ten years old. Thirty-five obese children received a fish oil capsule containing 45 mg EPA and 225 mg DHA (the supplemented group) and the others a virgin coconut oil capsule (the control group) for eight weeks, respectively. The changes in IL-6 and Hepcidin levels and iron status before and after supplementation were analyzed using MANCOVA test (α=0.05). Results: The study indicates a significant decrease of serum IL-6 by 1.8 pg/ml (95%CI 0.5-3.1 p=0.005), Hepcidin 9.6 nmol/l (95%CI 5.1-14.0 p=0.0001), and ferritin 10.2 ng/dl (95%CI 0.9-19.6 p=0.032). In addition, after the supplementation, we found an increase in serum iron by 13.6 mg/dl (95%CI 4.1-23.2 p=0.006) and transferrin saturation by 4.6% (95%CI 1.7-7.6 p=0.002). Conclusion: Supplementation with fish oil capsule containing EPA and DHA in obese children improved the iron status through decreasing serum IL-6 and Hepcidin.
References
- Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Philip M. Greaterprevalence of iron deficiency in overweight and obese children and adolescents.International Journal of Obesity, 2003;27:416-82. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweightchildren and adolescents: A risk group for Iron deficiency. Pediatrics, 2004; 114:104-8.3. Cepeda-Lopez AC, Osendarp SJM, Melse-Boonstra A, Aeberli I, Gonzalez-Salazar F,Feskens E, dkk. Sharply higher rates of iron deficiency in obese Mexican woman andchildren are predicted by obesity-related inflammation rather than by differences indietary iron intake. Am J Clin Nutr, 2011. doi: 10.3945/ajcn.110.005439.4. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC.Childhood obesity, other cardiovascular risk factors, and premature death. N Engl JMed, 2010; 362:485-93.5. Fretham SJB, Carlson ES, Georgieff MK. The role of iron in learning and memory.Adv Nutr, 2011; 2:112-21.6. Arslan N, Erdur B, Aydin A. Hormones and Cytokines in Childhood Obesity. IndianPediatrics, 2010; 47:829-39.7. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression throughSTAT3. Blood, 2006;108(9):3204-9.8. Ganz T. Hepcidin and iron regulation, 10 years later. Blood, 2011;117(17): 4425-33.9. Sanad M, Osman M, Gharib A. Obesity modulate serum hepcidin and treatmentoutcome of iron deficiency anemia in children: A case control study. Italian Journal ofPediatrics, 2011; 37(34):3-6.10. Calder PC. Omega-3 Fatty Acids and Inflammatory Processes. Nutrients, 2010;2:355-74.11. Ganz T, Nemetz E. Iron imports. IV. Hepcidin and regulation of body ironmetabolism. Am J Physiol Gastrointest Liver Physiol, 2006; 290:G199-203
How to Cite
Sidiartha, I. G. L., Bakta, I. M., Wiryana, I. M., Sutirtayasa, I. W. P., & Sjarif, D. R. (2017). Eicosapentaenoic acid and docosahexaenoic acid in fish oil capsule supplementation in obese children decreases serum interleukin-6 and hepcidin and improves iron status. Bali Medical Journal, 6(1), 97–101. https://doi.org/10.15562/bmj.v6i1.410
